Mira's wrong TB diagnosis

Mira's message to all

India's position in eliminating TB

Obstacles in making India TB free

The layers of challenges

"Worsening resistance is a major setback"

Importance of grassroot TB testing

Explained: What is MDR-TB issue?

New treatment: The BPaLM regimen

Is the TB issue being neglected globally?

What can India do more to eleminate TB?

Closing thoughts

India reported 24 lakh TB cases last year, despite a government program launched in 2018 aiming to eliminate TB by 2025. This conversation examines critical advancements, including innovative diagnostics, improved treatment regimens, and public-private partnerships. Host Vikas Dandekar is joined by a distinguished panel comprising Dr. Urvashi Singh, Deputy Director General (TB) from the Ministry of Health and Family Welfare; Dr. Randeep Guleria, Former Director of AIIMS and a public health advocate; Dr. Alpa Dalal, Head of Pulmonary Medicine at Jupiter Hospital and Honorary Chest Physician at Sewri TB Hospital, Mumbai; and Mr. Sriram Natarajan, Director and CEO of Molbio Diagnostics. Together, they address key challenges such as stigma, treatment adherence, and the role of nutrition in recovery. Learn how India is leveraging technology, community involvement, and government initiatives to tackle one of its most pressing public health challenges. What progress has been made, where do we stand, and what’s next in the fight against tuberculosis? Tune in to find out.

Check out other interesting episodes from the host like: India’s Space Odyssey 2025, How will the H-1B furore pan out?, Building India’s $30 Trillion Future By 2047, Mint Street’s New Maestro, Explaining the Food Inflation Debate, India’s Big Dubai Probe and more!

You can follow Anirban Chowdhury on his social media: Twitter and Linkedin

Catch the latest episode of ‘The Morning Brief’ on ET Play, The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

India reported 24 lakh TB cases last year, despite a government program launched in 2018 aiming to eliminate TB by 2025. This conversation examines critical advancements, including innovative diagnostics, improved treatment regimens, and public-private partnerships. Host <a href="https://m.economictimes.com/etreporter/author-vikas-dandekar-479242213.cms">Vikas Dandekar</a> is joined by a distinguished panel comprising <a href="https://mohfw.gov.in/?q=whoswho-6">Dr. Urvashi Sing</a>h, Deputy Director General (TB) from the Ministry of Health and Family Welfare; <a href="https://www.medanta.org/hospitals-near-me/gurugram-hospital/speciality/internal-medicine/doctor/dr-randeep-guleria">Dr. Randeep Guleria</a>, Former Director of AIIMS and a public health advocate; <a href="https://www.linkedin.com/in/dr-alpa-dalal-103b1b98/">Dr. Alpa Dalal</a>, Head of Pulmonary Medicine at Jupiter Hospital and Honorary Chest Physician at Sewri TB Hospital, Mumbai; and <a href="https://www.linkedin.com/in/sriram-natarajan-526885202/">Mr. Sriram Natarajan</a>, Director and CEO of Molbio Diagnostics. Together, they address key challenges such as stigma, treatment adherence, and the role of nutrition in recovery. Learn how India is leveraging technology, community involvement, and government initiatives to tackle one of its most pressing public health challenges. What progress has been made, where do we stand, and what&rsquo;s next in the fight against tuberculosis? Tune in to find out.
Check out other interesting episodes from the host like: <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000682470705">India&rsquo;s Space Odyssey 2025</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000682183288">How will the H-1B furore pan out?</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000681498568">Building India&rsquo;s $30 Trillion Future By 2047</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000680629425">Mint Street&rsquo;s New Maestro</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000679419639">Explaining the Food Inflation Debate</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000679281826">India&rsquo;s Big Dubai Probe</a> and <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777">more!</a>
You can follow Anirban Chowdhury on his social media: <a href="https://twitter.com/AnirbanET">Twitter</a> and <a href="https://www.linkedin.com/in/anirban-chowdhury-b5067219/">Linkedin</a>
Catch the latest episode of &lsquo;The Morning Brief&rsquo; on <a href="https://www.etplay.com/etplay">ET Play</a>, <a href="https://economictimes.indiatimes.com/podcast?from=mdr">The Economic Times Online</a>,<a href="https://open.spotify.com/show/6PL5kfPbwURBEu6fHCVTOL?si=26ec0fbfa7134fea"> Spotify</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777">Apple Podcasts</a>, <a href="https://www.jiosaavn.com/shows/the-morning-brief/1/GNPiFQD2xpY_">JioSaavn</a>, <a href="https://music.amazon.in/podcasts/f378141f-9afb-495d-83da-9b08ec5047ac/the-morning-brief">Amazon Music</a> and <a href="https://www.youtube.com/@theetpodcasts">Youtube</a>.

To make sense of the week’s hottest stories in business, economy, politics and markets, journalists from the Economic Times chat with reporters and industry leaders in this thrice-weekly (Tuesday, Thursday, Friday) podcast.

The Morning Brief

India vs TB: Where are we at?

Advertisement